JSJasper Therapeutics, Inc. JSPR NASDAQ · Healthcare · United States
$11.77 -13.96% -$1.91
- Market cap
- $13.1M
- Enterprise value
- $6.01M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- -
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -1,305.0%
- Gross margin
- -
- Net margin
- -
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 3.31
- Free float
- 89.6%
About the company
Jasper Therapeutics, Inc. (JSPR) is a biotechnology company based in the USA that specializes in researching and developing novel therapeutic approaches in the field of hematopoiesis and cell therapy. The company focuses on treating hematological disorders and other diseases related to blood formation and the immune system. Their research centers on the use of stem cells and cell therapy to regenerate hematopoietic tissues and treat various diseases. Jasper Therapeutics aims to bring innovative and effective treatment methods that could revolutionize medical practices and improve the quality of life for patients. With the growing interest in the biotechnology industry, shares of Jasper Therapeutics, Inc. could present an intriguing investment opportunity for those who believe in the prospects of biotechnology and new therapeutic approaches.
Sector
Healthcare
Industry
Biotechnology
CEO
Jeetinder Singh Mahal
Employees
22
Headquarters
Redwood City
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: It missed profit estimates 5 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $135.3M against $69.0K.
- What to watch: It passes only 2 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number